GSS vs IPD

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

GSS

GENETICSIG FPO [GSS]

54MEDIUM

IPD

IMPEDIMED FPO [IPD]

48LOW

Score Breakdown

GSS IPD
Technical
50
57
Catalyst
65
55
Sentiment
50
50
Fundamental
59
95
Momentum
31
30
Risk Gate
50
27

Key Metrics

GSS Metric IPD
$14.5MMarket Cap$22.0M
877KAvg Volume (20d)6.9M
N/AShort InterestN/A
$0.43052-Week High$0.059
$0.05752-Week Low$0.005
-1.6%Daily Change+0.0%
$0.063Reference Price$0.006
-22.8%ROE-117.9%
-56.5%Profit Margin-171.3%

Active Signals

GSS Signals

●RSI drifting toward oversold territory — worth watching
●Trading below both moving averages — the trend is working against this one
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (12 quarters)
●Low P/S ratio (0.7x)
●EPS estimates revised downward (-10pts)
●Near 52-week low (2% of range)

IPD Signals

●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Below the 200-day average — the long-term trend is still working against it
●Adequate cash runway (5 quarters)
●Low P/S ratio (1.5x)
●Strong revenue growth (+25%)
●Piotroski F-Score weak (3/9, low-confidence approx)
●EPS estimates revised upward (+10pts)
●Near 52-week low (2% of range)

Ask Scout AI to compare GSS and IPD in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

GSS vs MYX →GSS vs NTI →GSS vs OCC →GSS vs PHX →GSS vs PKY →
GSS Full Analysis → IPD Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).